Grants for Independent school districts - Food and Nutrition

Will County has allocated $225,000 in grant dollars to support the important work of early child care providers in Will County. Donor Name: Will County State: Illinois County: Will County (IL) Type of Grant: Grant Deadline: 05/22/2024 Size of the Grant: $1000 to $10,000 Grant Duration: Grant Duration Not Mentioned Details: Child care providers pursue grant funding for educational materials, developmental support services, and/or improvements to physical space and technology. The Program will provide grants to eligible Applicants including, but not limited to, the following improvements: Educational Materials Books, paper, crayons, art supplies, fine motor toys, STEAM/STEM resources, etc. Physical Environment Safety and sanitation (e.g. kitchenware, baby gates, outlet covers, door locks, safe cleaning supplies, gloves, changing tables, cubbies, etc.); Furniture, rugs, inviting child friendly environment; Paint, air filtration, water filtration; Signage; Gross motor materials/safe playground/fencing  Technology Security system(s)-Inside/Out & installation; Computer software to enhance services/tracking, enrollment, meals, waitlists, parent communication, screenings for children, etc.; Hardware for faculty (smartboard, tablets, laptops, projector/screen); Upgrading parent communication systems; Webpage software/updates Developmental Supports Developmental Screening Tools; Hiring consultant(s)/trainer(s) to meet the needs of workforce, families, children; Social emotional program enhancement; Sensory related program enhancements (e.g. soundproofing, weighted blankets, etc.); Health screenings (mobile dental/health van, hearing and vision, medical checkup, remote services); Hiring remote services that target children’s needs (gross motor, language, fine motor, dramatic play, etc.); Healthy meal programming/food purchases  Funding Information Award Ceiling: $10,000.00 Award Floor: $2,000.00 Project Period The period of performance is expected to be June 14, 2024 through October 31, 2024, pre-award costs may be permitted with approval. Use of funds Child care providers can pursue grant funding for educational materials, developmental support services, and improvements to physical space and technology. Allowable use of funds include, but are not limited to, the following: Educational Materials Physical Environment Technology Developmental Supports Targeted Population Providers who serve the following populations will also receive priority: DCFS Licensed childcare providers in the Will County R3 Zones who serve children ages birth to five years of age DCFS Licensed Providers who receive Child Care Assistance Program (CCAP) funds DCFS Licensed Providers who serve children 0-5 years of age whose families speak English as a Second Language (ESL) DCFS Licensed Providers who qualify for the Early Intervention program (program serves children birth to 2 years 11 months with developmental delays) DCFS Licensed Providers who serve children with a developmental or medical diagnosis (children birth to five years) DCFS Licensed Providers who serve children with an active Individually Education Plan (IEP) in the public school system (ages 3-5 years) Eligibility Criteria All applicants must be a DCFS Licensed Childcare Provider located in Will County. For more information, visit Will County.

This grant provides funding to professionals with quantitative science backgrounds to develop their research skills in biomedical fields, enabling them to tackle significant health challenges through innovative approaches.

This Notice of Funding Opportunity (NOFO) invites applications for Cystic Fibrosis (CF) Research and Translation Core Centers. CF Research and Translation Core Centers are designed to support both basic and clinical research on Cystic Fibrosis. CF Research and Translation Core Centers support three primary research-related activities: Research Core services; a Pilot and Feasibility program; and an Administrative Core with an enrichment program. Core Centers provide shared resources to support research to develop and test new therapies for CF and to foster collaborations among institutions with a strong existing research base in CF. The NIDDK currently supports seven CF Research and Translation Centers located at institutions with documented programs of research excellence in basic and clinical CF Research. Information about the currently funded CF Research and Translation Centers may be found at: https://www.niddk.nih.gov/research-funding/research-programs/cystic-fibrosis-research-translation-centers or https://www.cysticfibrosiscenters.org/.

Summer Meal Program Expansion Grant Applications for the new Summer Meal Program Expansion Grant program are now open through May 7! Program Overview: The Iowa Department of Education has received $900,000 to support the enhancement and expansion of summer meal programs in currently underserved and eligible areas. Program Details: Funding Source: $900,000 from the U.S. Department of Agriculture (USDA) Purpose: Enhance and expand summer meal programs in underserved areas. Target Audience: Iowa children ages 18 and under. Programs Supported: Summer Food Service Program (SFSP) and Seamless Summer Option (SSO). Grant Opportunity: Provides additional revenue source for summer meal programs beyond federal meal reimbursement. Allowable Expenses: Enhancing meal quality, incorporating locally grown foods, updating program equipment, conducting program outreach, and operational/administrative personnel expenses not fully covered through meal reimbursement. Eligible Sites for Expansion: Possible new meal site locations include: Schools Community buildings Libraries Apartment complexes Parks Swimming pools Splash pads Churches Other public sites where children gather Non-Congregate Distribution: Non-congregate distribution may be an option for State agency approved sponsors in rural areas unserved by a congregate meal service. Application Deadline: May 7 Don't miss this opportunity to expand summer meal programs and ensure Iowa children have access to healthy meals during the summer break! Apply now!

The purpose of this Notice of Funding Opportunity (NOFO) is to solicit grant applications from neutral, independent institutions and/or organizations to support meetings (e.g., conferences, workgroups, roundtables) that convene a broad range of multiple stakeholders, including those with relevant expertise, to explore, research, and address issues related to medical products, policy, and surveillance methods and systems. Support includes, but is not limited to the design, planning, execution, synthesis, summary, and communication of findings from these forums to a broad range of organizations and individuals.

Under the Resilient Food Systems Infrastructure Program managed by the Pennsylvania Department of Agriculture (PDA) and funded by the USDA Agricultural Marketing Service (AMS), Simplified Equipment-Only Grants are designed to support Pennsylvania's food system transformation. These grants, focusing on equipment purchases for small to mid-size producers and processors, aim to diversify, distribute, and localize food systems to enhance consumer access, producer options, and rural community markets. Grant amounts range from $10,000 to $100,000, requiring no cost sharing. Eligible equipment expenses include purchase costs, delivery, and installation if included in the official bid. Applications are accepted electronically, with project completion required by June 30, 2026.

This grant provides funding for clinicians to conduct independent clinical trials and develop their research skills through mentorship, focusing on patient-oriented studies that directly involve human subjects.

This grant provides funding to support clinicians in developing their research careers focused on patient-oriented studies, allowing them to gain skills and experience while working closely with human subjects.

The Rhode Island Strategic Prevention Framework (SPF) Partnerships for Success (PFS) program is specifically tailored to address gaps in alcohol and marijuana use prevention among youth and young adults aged 12-18 in certain communities. These communities include Newport, Tiverton, Burrillville, and Exeter-West Greenwich, identified as high-need areas for prevention efforts. The program, administered by the Rhode Island Department of Behavioral Healthcare, Developmental Disabilities & Hospitals (BHDDH), collaborates with local community prevention providers to implement evidence-based programming aimed at reducing underage and problematic use of alcohol and marijuana among middle and high school students. Eligible applicants for funding include: Local government entities Academic institutions Non-profit organizations Other relevant agencies Schools/school districts Applicants are required to implement one or more preapproved evidence-based practices from a provided list. The aim is to ensure that interventions are grounded in proven strategies for effectiveness. Key details of the funding opportunity: Funds Available: $200,000.00 Award Amount: $50,000.00 (minimum and maximum) Number of Awards: 4 Average Award Size: $50,000.00 Matching Required: No Through this targeted initiative, the Rhode Island SPF PFS program seeks to empower local stakeholders and organizations to address substance abuse prevention needs in their communities effectively. By providing funding, training, and technical assistance, BHDDH aims to support the implementation of evidence-based prevention strategies tailored to the unique challenges and needs of each identified community.

This funding opportunity supports U.S. institutions in developing educational programs that provide undergraduate and early-stage graduate students with hands-on research experiences in kidney technology development and entrepreneurship.

The objective of this Notice of Funding Opportunity (NOFO) is to invite new and renewal applications for the Rare Diseases Clinical Research Consortia (RDCRC) that comprise the Rare Diseases Clinical Research Network (RDCRN). The RDCRCs are intended to advance and improve diagnosis, management, and treatment of numerous, diverse rare diseases through highly collaborative, multi-site, patient-centric, translational and clinical research. Special emphasis will be placed on the early and timely identification of individuals with rare diseases and clinical trial readiness.

This Notice of Funding Opportunity (NOFO) requests applications to explore human pancreatic tissues and the immune compartment for the discovery of specific signaling or processing pathways that may contribute to the asymptomatic phase of T1D, the discovery of early biomarkers of T1D pathogenesis, the development of diagnostic tools for the detection and staging of early T1D in at-risk or recently-diagnosed individuals, and/or the identification and biological validation of therapeutic targets for the development of preventative or early treatment strategies. Successful applicants will join the Consortium on Beta Cell Death and Survival (CBDS), whose mission is to better define and detect the mechanisms of beta cell stress and destruction central to the development of T1D in humans, with the long-term goal of protecting the residual beta cell mass in T1D patients as early as possible in the disease process, and of preventing the progression to autoimmunity. The CBDS is part of a collaborative research framework, the Human Islet Research Network (HIRN, https://hirnetwork.org/), whose overall mission is to support innovative and collaborative translational research to understand how human beta cells are lost in T1D, and to find innovative strategies to protect and replace functional beta cell mass in humans. This NOFO will only support studies with a primary focus on increasing our understanding of human disease biology (as opposed to rodent or other animal models). This NOFO will not accept applications proposing a clinical trial.

The main objective of this NOFO is to foster development and testing of technologies adaptable to aging-related changes in older adults (aged 65 years or older) with T1D to improve diabetes management and quality of life. Older adults may have increased vulnerability to hypoglycemia, cognitive impairment and/or multiple co-morbidities which may affect the risks and benefits of these technologies in this population. Projects will be funded to a) develop and test new technologies and b) to adapt and test existing technologies. It is expected that aging-adaptive diabetes technologies that address barriers for use among older adults with T1D will improve usability, adoption and adherence decreasing the risk of hypoglycemia (and hypoglycemia unawareness) while enhancing glycemic control, facilitating better diabetes management, and improving quality of life for these individuals and their caregivers.

This Notice of Funding Opportunity (NOFO) invites applications for Diabetes Research Centers (DRCs) that are designed to support and enhance the national research effort in diabetes, its complications, and related endocrine and metabolic diseases. The purpose of this Centers program is to bring together basic and clinical investigators to enhance communication, multidisciplinary collaboration, and effectiveness of ongoing research in Diabetes Research Center topic areas. By providing shared access to specialized technical resources (research cores) and supporting a Pilot and Feasibility Program (P and F), DRCs are intended to create an environment that provides the capability for accomplishments greater than those that would be possible by individual research project grant support alone. New Center programs that bring in diverse perspectives, propose unique scientific themes, or provide innovative resources are encouraged. Emphasis will be placed on Center programs that propose enhanced synergies with other NIDDK-funded programs as well as providing a rich mentoring environment for future diabetes researchers. This NOFO requires a Plan for Enhancing Diverse Perspectives (PEDP), which will be assessed as part of the scientific and technical peer review evaluation. Applications that fail to include a PEDP will be considered incomplete and will be withdrawn. Applicants are strongly encouraged to read the NOFO instructions carefully and view the available PEDP guidance material.

This program provides funding to public school districts and area career and technical schools for necessary improvements to their facilities.

This funding opportunity provides financial support for researchers developing innovative, non-opioid treatments for various types of pain, with a focus on early-stage studies and collaboration with underrepresented populations.

This funding opportunity supports innovative pilot research projects that explore the biological, behavioral, and social factors influencing HIV-related health issues, particularly those affecting kidney and digestive diseases.

Notice of Funding Opportunity Description Background The Food and Drug Administration (FDA) protects the public health by ensuring that medical products intended to be marketed in the United States are safe and effective for their intended use. FDA stakeholders are exploring innovative ways to produce scientific evidence in support of regulatory submissions, including the development of new data sources, study designs, methodologies, and technologies. FDA encourages and facilitates the use of such innovative approaches while ensuring that the scientific evidence supporting marketing approvals meet our high evidentiary standards. The Prescription Drug User Fee Act VII (PDUFA VII) commitment letter represents the product of discussions between the FDA, regulated industry, and public stakeholders, as mandated by Congress. The performance and procedural goals and other commitments specified in the PDUFA VII commitment letter apply to aspects of the human drug review program that are important for facilitating timely access to safe, effective, and innovative new medicines for patients. The commitment letter includes goals relating to the use of digital health technologies (DHTs) to support drug development and review. A DHT is a system that uses computing platforms, connectivity, software, and/or sensors, for health care and related uses. DHTs for remote data acquisition in clinical investigations can include hardware and/or software to perform one or more functions. DHTs may rely on or work with other technologies that support their operation, such as general-purpose computing platforms (e.g., smartphones) and communication networks. Among other activities relating to the use of DHTs, FDA has established a Framework for the Use of DHTs in Drug and Biological Product Development to guide the use of DHT-derived data in regulatory decision-making for drugs (hereinafter Framework ). The Framework highlights FDA’s DHT efforts including workshops and demonstration projects; engagement with stakeholders; establishment of internal processes to support the evaluation of DHTs for use in drug development; promotion of shared learning and consistency regarding DHT-based policy, procedure, and analytic tool development; and publication of guidance documents. In addition, FDA’s webpage DHTs for Drug Development (available at: https://www.fda.gov/science-research/science-and-research-special-topics/digital-health-technologies-dhts-drug-development) provides an overview of the ongoing DHT efforts, including demonstration projects. A variety of project types are welcomed under this NOFO, applicable to drugs and biologics (not devices). FDA is particularly interested in projects that evaluate the use of DHTs in drug development. Project Objectives The overarching goal of this notice of funding opportunity (NOFO) is to explore the role of DHTs (e.g., actigraphy, photography, environmental sensors) in the evaluation of new drugs. These projects may involve engagement with researchers from academia, the biopharmaceutical industry, patient groups, and other stakeholders. The objectives of these projects are to advance DHTs for clinical drug development, expand the ability to capture early manifestations of chronic diseases, determine outcomes in populations with unmet medical needs and enhance convenience for trial participants by allowing for remote data acquisition in clinical investigations. The scope includes, but is not limited to, projects that focus on: Comparing digital measurements to traditional measurements in clinical trials to evaluate drugs Developing and evaluating novel endpoints using DHTs to address unmet needs for drug clinical trials (e.g., use of environmental sensors to capture apnea in pediatric patients) Comparing metrics to evaluate continuous measurements (e.g., maximum activity and stamina) Capturing early manifestations of chronic diseases (e.g., dementia) through the use of DHTs

The Shullsburg Fund, established in 2004 by area citizens, serves as a permanent funding source dedicated to enhancing the quality of life in and around Shullsburg. Managed as a component of the Community Foundation of Southern Wisconsin, it annually redistributes a portion of its earnings to finance projects and programs that positively impact community life. The fund focuses on supporting non-profit organizations, the local school district, and local government agencies with charitable initiatives. Grants are ceremoniously awarded in June each year, underlining the fund's commitment to community development and welfare. Grant renewed every year. Grant annual deadline: May 15th

The purpose of the NIH Research Conference Grant (R13) is to support high quality conferences that are relevant to the public health and to the scientific mission of the participating Institutes and Centers.